Intangible Assets (Tables)

6 Months Ended

Mar. 31, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets at March 31, 2013 and September 30, 2012 consist of the following:

	Useful	Gross		Accumulated
March 31, 2013	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	5,275,668	$	2,516,280	$	2,759,388
Know How	15		512,000		162,214	$	349,786
Trade Names	15 - Indefinite		527,389		70,522	$	456,867
Biomedical Technologies	5		300,000		90,003	$	209,997
		$	6,615,057	$	2,839,019	$	3,776,038

	Useful	Gross		Accumulated
September 30, 2012	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	7,858,775	$	2,257,533	$	5,601,242
Know How	15		512,000		145,147		366,853
Trade Names	15 - Indefinite		558,435		63,222		495,213
Biomedical Technologies	5		300,000		60,003		239,997
		$	9,229,210	$	2,525,905	$	6,703,305

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Amortization expense for the three months ended March 31, 2013 and 2012 was $143,506 and $162,802respectively. Amortization expense for the six months ended March 31, 2013 and 2012 was $324,774 and $325,605, respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

	2013 (6 Months)		2014		2015		2016		2017		Thereafter		Total
Acquired Customer Base	$	271,543	$	543,085	$	543,085	$	543,085	$	543,085	$	315,504	$	2,759,387
Know How		17,067		34,133		34,133		34,133		34,133		196,187		349,786
Trade Names		7,300		14,600		14,600		14,600		14,600		72,995		138,695
Biomedical Technologies		30,000		60,000		60,000		59,997		-0-		-0-		209,997
	$	325,910	$	651,818	$	651,818	$	651,815	$	591,818	$	584,686	$	3,457,865